首页> 外文期刊>Biological Trace Element Research >Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension
【24h】

Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension

机译:铜改变原发性高血压患者红细胞膜钠运输系统的活性

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the study was to verify the hypothesis if copper could influence the activity of sodium-transporting systems in erythrocyte membrane that could be related to essential hypertension. The examined group of patients consisted of 15 men with hypertension. The control group was 11 healthy male volunteers. The Na+/H+ exchanger (NHE) activity in erythrocytes was determined according to Orlov et al. The activity of transporting systems (ATP-Na+/K+; co-Na+/K+/Cl−; ex-Na+/Li+; free Na+ and K+ outflow [Na+, K+-outflow]) was determined according to Garay's method. The concentration of copper in plasma was assessed using atomic absorption spectrometry. The activity of ATP-Na+/K+ (μmol/L red blood cells [RBCs]/h) in hypertensive patients was 2231.5±657.6 vs 1750.5±291 in the control (p<0.05), the activity of co-Na+/K+/Cl− (μmol/L RBCs/h) in hypertensives was 171.3±77.9 vs 150.7±53.9 in the control (NS). Na+-outflow (μmol/L RBCs/h) in hypertensives was 118.3±51.6 vs 113.3±24.4 in the control (NS). The K+-outflow (μmol/L RBCs/h) in hypertensives was 1361.7±545.4 vs 1035.6±188.3 in the control (NS). The activity of ex-Na+/Li+ (μmol/L RBCs/h) in hypertensive patients was 266.1±76.1 vs 204.1±71.6 in the control (p<0.05). NHE activity (mmol/L RBCs/h) in hypertensives was 9.7±2.96 vs 7.7±1.33 in the control (p<0.05). In hypertensive patients, negative correlation was found between the activity of Na+/K+/Cl− co-transport and plasma copper concentration (R s=−0.579, p <0.05) and between the activity of ex-Na+/Li+ and plasma copper concentration (R s=−0.508, p<0.05). Plasma copper concentration significantly influences the activity of sodium transporting systems in erythrocyte membrane. Copper supplementation could be expected to provide therapeutic benefits for hypertensive patients.
机译:该研究的目的是验证铜是否会影响可能与原发性高血压有关的红细胞膜钠运输系统活性的假说。所检查的患者组由15名高血压患者组成。对照组是11名健康的男性志愿者。根据Orlov等人的方法测定红细胞中的Na + / s + / H + 交换子(NHE)活性。转运系统(ATP-Na + / K + ; co-Na + / K + / Cl-; ex-Na + / Li + ;根据Garay的方法确定了游离的Na + 和K + 流出[Na + ,K + -流出]。使用原子吸收光谱法评估血浆中铜的浓度。高血压患者的ATP-Na + / K + (μmol/ L红细胞[RBCs] / h)活性为2231.5±657.6,而对照组为1750.5±291(p <0.05),高血压患者的co-Na + / K + / Cl-(μmol/ L RBCs / h)活性为171.3±77.9,而对照组(NS)为150.7±53.9。高血压患者的Na +流出(μmol/ L RBCs / h)为118.3±51.6,而对照组(NS)为113.3±24.4。高血压患者的K +流出(μmol/ L RBCs / h)为1361.7±545.4,而对照组(NS)为1035.6±188.3。高血压患者的前Na + / Li + (μmol/ L RBCs / h)活性为266.1±76.1,而对照组为204.1±71.6(p <0.05)。高血压患者的NHE活性(mmol / L RBCs / h)为9.7±2.96,而对照组为7.7±1.33(p <0.05)。在高血压患者中,Na + / K + / Cl-共转运活性与血浆铜浓度呈负相关(R s = − 0.579,p < 0.05),且前Na + / Li + 的活性与血浆铜浓度之间(R s == 0.508,p <0.05)。血浆铜浓度显着影响红细胞膜中钠转运系统的活性。铜的补充有望为高血压患者提供治疗益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号